Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Will The Nocturia Market Valuation Change Between Now And 2029?

Growth in the market size for nocturia has been robust over the past few years. Expectations are for an increase from $2.87 billion in 2024 to $3.1 billion in 2025, with a compound annual growth rate (CAGR) pegged at 8.0%. The upswing in the earlier period can be linked to factors such as the rising incidences of cardiovascular ailments, a surge in insomnia cases, an uptick in the aging population, heightened awareness about nocturia and related conditions, and growth in comorbidities.

The market of nocturia is predicted to experience robust expansion in the coming years, with projections indicating a growth to $4.2 billion by 2029, and a compound annual growth rate (CAGR) of 7.8%. This projected growth over the forecast period can be ascribed to a rising frequency of bladder constriction issues and urinary tract inflammations, escalated cases of nocturia due to various risk factors, excessive fluid intake leading to nocturia, growing consciousness of the link between nocturia, sleep disorders, and kidney health, and an expanding elderly population. Key trends expected to feature over the forecast period encompass progress in diagnostic techniques, the creation of novel drugs, intensified research and investment into the treatment of nocturia, advancements in both surgical and non-surgical treatments, and an emerging inclination towards personalized medicine.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21232&type=smp

What Underlying Factors Are Supporting The Nocturia Market Growth?

The increasing incidences of cardiovascular health issues are projected to be a significant driver for the expansion of the nocturia market. Cardiovascular diseases (CVDs), including conditions like heart disease, stroke, hypertension, and disorders of the heart and blood vessels, are becoming more common due to factors such as an aging population, inactive lifestyles, poor nutrition, tobacco use, overconsumption of alcohol, obesity, elevated blood pressure, high cholesterol levels, diabetes, and genetic factors. Nocturia is frequently observed as a symptom in patients with cardiovascular diseases, which has led to an increased demand for diagnostic and treatment solutions. As global cardiovascular disease rates continue to climb because of aging demographics and unhealthy lifestyle choices, the necessity for efficient nocturia management will also increase. For example, the Centers for Disease Control and Prevention reported in May 2024 that heart disease was the cause of 702,880 deaths in 2022, accounting for 20% of total deaths in the US. Every year, an estimated 805,000 people suffer a heart attack, with 605,000 being first-time incidents and 200,000 involving people with a previous history. Hence, the rising prevalence of cardiovascular diseases is fuelling the growth of the nocturia market.

Which Sub-Segments Are Driving Growth Within The Nocturia Market?

The nocturiamarket covered in this report is segmented –

1) By Drug: Anticholinergic Drugs; Desmopressin; Antibiotics; Antispasmodic; Other Drugs

2) By Indication: Mixed Nocturia; Low Nocturnal Bladder Capacity; Nocturnal Polyuria; Global Polyuria

3) By Causes: Urological Infection; Tumor Of The bladder; Diuretic Medications; Regular Alcohol Or coffee; Liver infection; Diabetes; Pregnancy; Other Causes

4) By End User: Hospitals; Home Care; Clinics

Subsegments:

1) By Anticholinergic Drugs: Oxybutynin; Tolterodine; Solifenacin; Darifenacin; Fesoterodine

2) By Desmopressin: Intranasal Desmopressin; Oral Desmopressin

3) By Antibiotics: Nitrofurantoin; Trimethoprim; Fosfomycin; Other Antibiotics

4) By Antispasmodic: Hyoscine Butylbromide; Flavoxate; Other Antispasmodics

5) By Other Drugs: Alpha-blockers; Beta-3 Agonists; Diuretics; Other Pharmacological Treatments

What Key Trends Are Driving Growth In The Nocturia Market?

In the nocturia market, companies are developing patient-friendly products such as orally disintegrating tablets (ODTs) to improve convenience and compliance. ODTs dissolve rapidly in the mouth without water, benefiting patients who struggle with swallowing. For instance, in July 2024, Adalvo Limited, a Malta-based pharma company, launched Desmopressin ODT in Europe for conditions causing excessive fluid loss like central cranial diabetes insipidus. This synthetic vasopressin tablet helps manage diabetes insipidus, excessive urination, and bedwetting by reducing water excretion. It is also used to treat mild to moderate hemophilia A and von Willebrand disease by stimulating clotting factor release.

Which Companies Hold A Competitive Edge In The 1461 Market?

Major companies operating in the nocturia market are Pfizer Inc, Merck & Co. Inc, AbbVie Inc, Sanofi S.A, GlaxoSmithKline plc, Viatris Inc, Boehringer Ingelheim International GmbH, Otsuka Pharmaceutical Co. Ltd, Astellas Pharma Inc, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd, Ferring Pharmaceuticals A/S, Avadel Pharmaceuticals plc, UroGen Pharma Ltd, Sanwa Kagaku Co. Ltd., Urovant Sciences Inc, Serenity Pharmaceuticals LLC, Vantia Therapeutics Inc, AA Pharma Inc, Wellesley Pharmaceuticals Inc

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/nocturia-global-market-report

Which Region Dominates The Nocturia Market Today?

North America was the largest region in the nocturia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nocturia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21232&type=smp

Browse Through More Reports Similar to the Global Nocturia Market 2025, By The Business Research Company

Sleep Apnea Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/sleep-apnea-devices-global-market-report

Sleep Tech Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/sleep-tech-devices-global-market-report

Sleep Testing Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/sleep-testing-services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model